Andrew Edge and Karima Hudson joined the firm on 19 April and Andrew McLean and Chris Cowley start with the firm as partners on 4 May, following completion of their notice periods.
Andrew Edge is a corporate lawyer specialising in high value public and private M&A, joint venture, venture IPOs and secondary fundraisings, with a particular focus on the life sciences sector. As former head of Stephenson Harwood's corporate department, he is recognised by market bodies, the legal media and international clients as one of the leading corporate M&A lawyers in the market. He has renowned experience of the life sciences sector with a particular focus on biotech and pharmaceuticals industries.
Karima Hudson is a specialist M&A lawyer in the healthcare sector advising both operators and investors, and former head of Stephenson Harwood's healthcare team.